Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.
about
A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiformeDendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trialsAdvances in diagnostic and treatment modalities for intracranial tumors.Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.Canine distemper virus infection leads to an inhibitory phenotype of monocyte-derived dendritic cells in vitro with reduced expression of co-stimulatory molecules and increased interleukin-10 transcription.Engineering the brain tumor microenvironment enhances the efficacy of dendritic cell vaccination: implications for clinical trial design.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.New therapeutic approaches for malignant glioma: in search of the Rosetta stonePreoperative cerebrospinal fluid cytokine levels and the risk of postoperative delirium in elderly hip fracture patientsDendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials.Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?Stem cell delivery of therapies for brain disorders.Immunotherapy for canine cancer--is it time to go back to the future?Canine brain tumours: a model for the human disease?Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease.Cerebrospinal Flt3 ligand correlates to tau protein levels in primary Sjögren's syndrome.Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.
P2860
Q26849375-0EB3711E-618C-4D44-B249-54EDF14B9A01Q27014829-A16D0479-52DE-478D-B8AE-2FB6060E44EDQ30358150-C60C8D80-26E1-4598-B8AB-44CF41BE205EQ34443707-93FBD8D1-20D6-4E84-A140-B5503C607AC4Q35158077-DEF6A2CC-CE81-4F09-BABF-76B23D93597AQ35527165-E2B56E4A-51EE-48B3-923B-4E9962B9DAF8Q35799695-E4488436-50E8-4D96-B417-CCFA648CB8CFQ36224493-E10F62EB-5692-4BBB-AD92-8A9A5B10EDABQ37364851-D3B7EE78-7FB8-4D58-AB3A-C1C02D5E6694Q38059516-A9F1F896-5D35-4F0B-889B-7FA29181513FQ38218674-0BEC1E2E-A9C9-474E-97A4-EF5D8BF229E5Q38237392-58117BD8-8CAA-49E1-9A83-61A67C404E4DQ38363923-AB918755-3D26-4217-9095-973D57C42D48Q38491009-13B9359D-FE7F-4988-B5F2-96B11487C7CEQ39320340-9144B150-C6A2-4E32-A669-8B2CD42958E7Q44477864-2ECC9A70-6DBE-46CF-99E5-FA5AAE38422EQ48246344-C69FC705-B589-472E-BCDD-BEBD120CCEDC
P2860
Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Human Flt3L generates dendriti ...... r a dog glioma clinical trial.
@ast
Human Flt3L generates dendriti ...... r a dog glioma clinical trial.
@en
type
label
Human Flt3L generates dendriti ...... r a dog glioma clinical trial.
@ast
Human Flt3L generates dendriti ...... r a dog glioma clinical trial.
@en
prefLabel
Human Flt3L generates dendriti ...... r a dog glioma clinical trial.
@ast
Human Flt3L generates dendriti ...... r a dog glioma clinical trial.
@en
P2093
P2860
P1433
P1476
Human Flt3L generates dendriti ...... r a dog glioma clinical trial.
@en
P2093
A K M Ghulam Muhammad
Chunyan Liu
Dorothy Khan
G Elizabeth Pluhar
John D Young
John R Ohlfest
Julie Avalos
Kader Yagiz
Kolja Wawrowsky
Mariana Puntel
P2860
P304
P356
10.1371/JOURNAL.PONE.0011074
P407
P577
2010-06-11T00:00:00Z